New medications and treatments for ovarian cancer are constantly being developed. These must be shown to be safe and effective before doctors can prescribe them to patients. Through clinical trials, researchers test the effects of new drugs on a group of volunteers with ovarian cancer. Following a strict protocol and using carefully controlled conditions, researchers evaluate the investigational drugs under development and measure the ability of the new drug to treat ovarian cancer, its safety, and any possible side effects.
Some patients with ovarian cancer are reluctant to take part in clinical trials for fear of getting no treatment at all. This is not always the case. Patients who participate in clinical trials may receive the most effective therapy available for their condition -- or they may receive treatments that are being evaluated for future use. The drugs being tested may be even more effective than the current ovarian cancer treatment, or they may be found to be ineffective or too toxic. The specifics about a particular clinical trial should be discussed with your doctor.
Flanking the uterus are the two ovaries, each about the size of an almond, which produce eggs and female hormones. Ovarian cancer can occur at any age, even in childhood, but is most common after menopause. The disease accounts for about 22,000 new cases and almost 15,000 deaths annually in the U.S.
During her childbearing years, a woman's ovaries deliver eggs to the uterus through the fallopian tubes. The ovaries are susceptible to several types of growths, which are often benign cysts,...
This web site, developed by the nonprofit Coalition of Cancer Cooperative Groups, is an unbiased cancer clinical trial matching and navigation service enabling patients to search for cancer trials based on disease and location.